森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/06 | 2,064 | 2,066 | 2,061 | 2,064 | ±0 | ±0% | 1,000 |
| 2024/09/05 | 2,065 | 2,075 | 2,061 | 2,064 | -1 | ±0% | 900 |
| 2024/09/04 | 2,081 | 2,099 | 2,065 | 2,065 | -31 | -1.5% | 2,000 |
| 2024/09/03 | 2,083 | 2,124 | 2,076 | 2,096 | +25 | +1.2% | 2,100 |
| 2024/09/02 | 2,089 | 2,089 | 2,071 | 2,071 | -1 | ±0% | 1,700 |
| 2024/08/30 | 2,060 | 2,076 | 2,051 | 2,072 | +9 | +0.4% | 1,800 |
| 2024/08/29 | 2,050 | 2,063 | 2,050 | 2,063 | +8 | +0.4% | 900 |
| 2024/08/28 | 2,048 | 2,055 | 2,047 | 2,055 | +6 | +0.3% | 1,200 |
| 2024/08/27 | 2,060 | 2,066 | 2,049 | 2,049 | +1 | ±0% | 1,200 |
| 2024/08/26 | 2,053 | 2,053 | 2,043 | 2,048 | -16 | -0.8% | 1,400 |
| 2024/08/23 | 2,040 | 2,072 | 2,039 | 2,064 | +26 | +1.3% | 3,700 |
| 2024/08/22 | 2,040 | 2,045 | 2,038 | 2,038 | -8 | -0.4% | 2,200 |
| 2024/08/21 | 2,039 | 2,046 | 2,033 | 2,046 | +2 | +0.1% | 1,200 |
| 2024/08/20 | 2,044 | 2,049 | 2,034 | 2,044 | +9 | +0.4% | 4,600 |
| 2024/08/19 | 2,033 | 2,044 | 2,032 | 2,035 | +3 | +0.1% | 2,200 |
| 2024/08/16 | 2,031 | 2,036 | 2,031 | 2,032 | +2 | +0.1% | 2,800 |
| 2024/08/15 | 2,030 | 2,035 | 2,019 | 2,030 | ±0 | ±0% | 2,500 |
| 2024/08/14 | 2,016 | 2,033 | 2,012 | 2,030 | +10 | +0.5% | 3,200 |
| 2024/08/13 | 2,036 | 2,036 | 2,013 | 2,020 | +7 | +0.3% | 1,900 |
| 2024/08/09 | 2,040 | 2,040 | 2,010 | 2,013 | -27 | -1.3% | 6,300 |
| 2024/08/08 | 2,055 | 2,060 | 2,035 | 2,040 | -5 | -0.2% | 4,500 |
| 2024/08/07 | 2,044 | 2,058 | 2,031 | 2,045 | +1 | ±0% | 1,700 |
| 2024/08/06 | 2,043 | 2,167 | 2,015 | 2,044 | -49 | -2.3% | 7,700 |
| 2024/08/05 | 2,079 | 2,167 | 2,019 | 2,093 | -31 | -1.5% | 17,000 |
| 2024/08/02 | 2,141 | 2,141 | 2,121 | 2,124 | -18 | -0.8% | 7,100 |
| 2024/08/01 | 2,148 | 2,148 | 2,141 | 2,142 | -4 | -0.2% | 1,600 |
| 2024/07/31 | 2,145 | 2,150 | 2,145 | 2,146 | +1 | ±0% | 300 |
| 2024/07/30 | 2,148 | 2,150 | 2,141 | 2,145 | +3 | +0.1% | 1,400 |
| 2024/07/29 | 2,165 | 2,165 | 2,142 | 2,142 | ±0 | ±0% | 2,800 |
| 2024/07/26 | 2,166 | 2,166 | 2,141 | 2,142 | +2 | +0.1% | 1,400 |
| 2024/07/25 | 2,155 | 2,155 | 2,140 | 2,140 | -18 | -0.8% | 3,500 |
| 2024/07/24 | 2,153 | 2,159 | 2,145 | 2,158 | +3 | +0.1% | 2,100 |
| 2024/07/23 | 2,163 | 2,163 | 2,149 | 2,155 | +5 | +0.2% | 1,600 |
| 2024/07/22 | 2,161 | 2,161 | 2,145 | 2,150 | -11 | -0.5% | 2,900 |
| 2024/07/19 | 2,164 | 2,172 | 2,161 | 2,161 | -6 | -0.3% | 900 |
| 2024/07/18 | 2,186 | 2,186 | 2,167 | 2,167 | -21 | -1% | 2,300 |
| 2024/07/17 | 2,180 | 2,200 | 2,161 | 2,188 | +29 | +1.3% | 3,600 |
| 2024/07/16 | 2,166 | 2,170 | 2,150 | 2,159 | +1 | ±0% | 3,100 |
| 2024/07/12 | 2,150 | 2,165 | 2,145 | 2,158 | +8 | +0.4% | 3,700 |
| 2024/07/11 | 2,141 | 2,153 | 2,140 | 2,150 | +9 | +0.4% | 3,100 |
| 2024/07/10 | 2,145 | 2,155 | 2,140 | 2,141 | -2 | -0.1% | 2,900 |
| 2024/07/09 | 2,155 | 2,155 | 2,139 | 2,143 | -12 | -0.6% | 7,400 |
| 2024/07/08 | 2,157 | 2,160 | 2,152 | 2,155 | -2 | -0.1% | 2,400 |
| 2024/07/05 | 2,167 | 2,167 | 2,157 | 2,157 | -10 | -0.5% | 5,600 |
| 2024/07/04 | 2,178 | 2,180 | 2,164 | 2,167 | -13 | -0.6% | 5,600 |
| 2024/07/03 | 2,186 | 2,190 | 2,180 | 2,180 | -5 | -0.2% | 2,800 |
| 2024/07/02 | 2,206 | 2,206 | 2,183 | 2,185 | -17 | -0.8% | 3,100 |
| 2024/07/01 | 2,185 | 2,208 | 2,184 | 2,202 | +17 | +0.8% | 3,200 |
| 2024/06/28 | 2,179 | 2,185 | 2,175 | 2,185 | +10 | +0.5% | 1,400 |
| 2024/06/27 | 2,181 | 2,181 | 2,172 | 2,175 | -8 | -0.4% | 1,800 |
251～
300
件表示中 / 3785件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 222,100円 | +0.3% | +9.2% | 2.93% | 12.64倍 | 0.75倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| Ｃｈｏｒｄｉａ | 15,000円 | - | - | 0.00% | - | 3.19倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| ＮＡＮＯ | 14,100円 | -30.6% | - | 0.00% | - | 3.72倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
| メディシノバ | 18,600円 | - | - | - | - | - |
|
- |
| カイオム | 13,400円 | +2.6% | - | 0.00% | - | 6.04倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
市場注目の銘柄
チャート関連のコラム
